| Print
Ardelyx (ARDX)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adultswith IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Address
34175 Ardenwood Boulrvard
Suite 200
Fremont
CA
USA
94555
Telephone
+1 510 7451700
Forecast key dates
| Name | Key Date |
|---|---|
| Ardelyx Inc First Quarter Earnings Conference Call for 2026 | 2026-05-01T16:30:00 |
| Ardelyx Inc First Quarter Earnings Results for 2026 | 2026-05-01T00:00:00 |
| Ardelyx Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-20T08:00:00 |
| Ardelyx Inc Fourth Quarter Earnings Results for 2025 | 2026-02-20T00:00:00 |
| Ardelyx Inc Annual Report for 2025 | 2026-02-20T00:00:00 |
| Ardelyx Inc Third Quarter Earnings Conference Call for 2025 | 2025-10-31T16:30:00 |
| Ardelyx Inc Third Quarter Earnings Results for 2025 | 2025-10-31T00:00:00 |
| Ardelyx Inc Second Quarter Earnings Conference Call for 2025 | 2025-08-01T16:30:00 |
| Ardelyx Inc Second Quarter Earnings Results for 2025 | 2025-08-01T00:00:00 |
| Ardelyx Inc Annual General Meeting for 2025 | 2025-06-13T08:30:00 |
| Ardelyx Inc First Quarter Earnings Conference Call for 2025 | 2025-05-01T16:30:00 |
| Ardelyx Inc First Quarter Earnings Results for 2025 | 2025-05-01T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.